Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Health Catalyst (HCAT) EPS (Weighted Average and Diluted) (2019 - 2026)

Health Catalyst filings provide 8 years of EPS (Weighted Average and Diluted) readings, the most recent being -$1.53 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 337.14% to -$1.53 in Q1 2026 year-over-year; TTM through Mar 2026 was -$3.74, a 225.22% decrease, with the full-year FY2025 number at -$2.55, down 121.74% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$1.53 in Q1 2026 for Health Catalyst, down from -$1.3 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.23 in Q2 2024 to a low of -$1.53 in Q1 2026.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.54 (2022), compared with a mean of -$0.59.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): soared 60.34% in 2024 and later plummeted 337.14% in 2026.
  • Health Catalyst's EPS (Weighted Average and Diluted) stood at -$0.66 in 2022, then increased by 21.21% to -$0.52 in 2023, then soared by 36.54% to -$0.33 in 2024, then plummeted by 293.94% to -$1.3 in 2025, then fell by 17.69% to -$1.53 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$1.53 (Q1 2026), -$1.3 (Q4 2025), and -$0.32 (Q3 2025) per Business Quant data.